Inhibition mechanism of L,D-transpeptidase 5 in presence of the β-lactams using ONIOM method

Gideon F. Tolufashe, Victor T. Sabe, Collins U. Ibeji, Monsurat M. Lawal, Thavendran Govender, Glenn E.M. Maguire, Gyanu Lamichhane, Hendrik G. Kruger, Bahareh Honarparvar

Research output: Contribution to journalArticle

Abstract

Tuberculosis (TB) is one of the world's deadliest diseases resulting from infection by the bacterium, Mycobacterium tuberculosis (M.tb). The L,D-transpeptidase enzymes catalyze the synthesis of 3 → 3 transpeptide linkages which are predominant in the peptidoglycan of the M.tb cell wall. Carbapenems is class of β-lactams that inactivate L,D-transpeptidases by acylation, although differences in antibiotic side chains modulate drug binding and acylation rates. Herein, we used a two-layered our Own N-layer integrated Molecular Mechanics ONIOM method to investigate the catalytic mechanism of L,D-transpeptidase 5 (LdtMt5) by β-lactam derivatives. LdtMt5 complexes with six β-lactams, ZINC03788344 (1), ZINC02462884 (2), ZINC03791246 (3), ZINC03808351 (4), ZINC03784242 (5) and ZINC02475683 (6) were simulated. The QM region (high-level) comprises the β-lactam, one water molecule and the Cys360 catalytic residue, while the rest of the LdtMt5 residues were treated with AMBER force field. The activation energies (ΔG#) were calculated with B3LYP, M06-2X and ωB97X density functionals with 6–311++G(2d, 2p) basis set. The ΔG# for the acylation of LdtMt5 by the selected β-lactams were obtained as 13.67, 20.90, 22.88, 24.29, 27.86 and 28.26 kcal mol−1respectively. Several of the compounds showed an improved ΔG# when compared to the previously calculated energies for imipenem and meropenem for the acylation step for LdtMt5. This model provides further validation of the catalytic inhibition mechanism of LDTs with atomistic detail.

Original languageEnglish (US)
Pages (from-to)204-210
Number of pages7
JournalJournal of Molecular Graphics and Modelling
Volume87
DOIs
StatePublished - Mar 1 2019

Fingerprint

Peptidyl Transferases
acylation
Lactams
Acylation
tuberculosis
meropenem
antibiotics
infectious diseases
Carbapenems
Molecular mechanics
linkages
functionals
Peptidoglycan
Imipenem
bacteria
field theory (physics)
enzymes
Antibiotics
drugs
activation energy

Keywords

  • Catalytic mechanism
  • L,D-transpeptidase 5 (Ldt)
  • Mycobacterium tuberculosis (M.tb)
  • ONIOM
  • QM/MM

ASJC Scopus subject areas

  • Spectroscopy
  • Physical and Theoretical Chemistry
  • Computer Graphics and Computer-Aided Design
  • Materials Chemistry

Cite this

Tolufashe, G. F., Sabe, V. T., Ibeji, C. U., Lawal, M. M., Govender, T., Maguire, G. E. M., ... Honarparvar, B. (2019). Inhibition mechanism of L,D-transpeptidase 5 in presence of the β-lactams using ONIOM method. Journal of Molecular Graphics and Modelling, 87, 204-210. https://doi.org/10.1016/j.jmgm.2018.11.009

Inhibition mechanism of L,D-transpeptidase 5 in presence of the β-lactams using ONIOM method. / Tolufashe, Gideon F.; Sabe, Victor T.; Ibeji, Collins U.; Lawal, Monsurat M.; Govender, Thavendran; Maguire, Glenn E.M.; Lamichhane, Gyanu; Kruger, Hendrik G.; Honarparvar, Bahareh.

In: Journal of Molecular Graphics and Modelling, Vol. 87, 01.03.2019, p. 204-210.

Research output: Contribution to journalArticle

Tolufashe, GF, Sabe, VT, Ibeji, CU, Lawal, MM, Govender, T, Maguire, GEM, Lamichhane, G, Kruger, HG & Honarparvar, B 2019, 'Inhibition mechanism of L,D-transpeptidase 5 in presence of the β-lactams using ONIOM method', Journal of Molecular Graphics and Modelling, vol. 87, pp. 204-210. https://doi.org/10.1016/j.jmgm.2018.11.009
Tolufashe, Gideon F. ; Sabe, Victor T. ; Ibeji, Collins U. ; Lawal, Monsurat M. ; Govender, Thavendran ; Maguire, Glenn E.M. ; Lamichhane, Gyanu ; Kruger, Hendrik G. ; Honarparvar, Bahareh. / Inhibition mechanism of L,D-transpeptidase 5 in presence of the β-lactams using ONIOM method. In: Journal of Molecular Graphics and Modelling. 2019 ; Vol. 87. pp. 204-210.
@article{a9d9e7c357334dc99269709f346ecadb,
title = "Inhibition mechanism of L,D-transpeptidase 5 in presence of the β-lactams using ONIOM method",
abstract = "Tuberculosis (TB) is one of the world's deadliest diseases resulting from infection by the bacterium, Mycobacterium tuberculosis (M.tb). The L,D-transpeptidase enzymes catalyze the synthesis of 3 → 3 transpeptide linkages which are predominant in the peptidoglycan of the M.tb cell wall. Carbapenems is class of β-lactams that inactivate L,D-transpeptidases by acylation, although differences in antibiotic side chains modulate drug binding and acylation rates. Herein, we used a two-layered our Own N-layer integrated Molecular Mechanics ONIOM method to investigate the catalytic mechanism of L,D-transpeptidase 5 (LdtMt5) by β-lactam derivatives. LdtMt5 complexes with six β-lactams, ZINC03788344 (1), ZINC02462884 (2), ZINC03791246 (3), ZINC03808351 (4), ZINC03784242 (5) and ZINC02475683 (6) were simulated. The QM region (high-level) comprises the β-lactam, one water molecule and the Cys360 catalytic residue, while the rest of the LdtMt5 residues were treated with AMBER force field. The activation energies (ΔG#) were calculated with B3LYP, M06-2X and ωB97X density functionals with 6–311++G(2d, 2p) basis set. The ΔG# for the acylation of LdtMt5 by the selected β-lactams were obtained as 13.67, 20.90, 22.88, 24.29, 27.86 and 28.26 kcal mol−1respectively. Several of the compounds showed an improved ΔG# when compared to the previously calculated energies for imipenem and meropenem for the acylation step for LdtMt5. This model provides further validation of the catalytic inhibition mechanism of LDTs with atomistic detail.",
keywords = "Catalytic mechanism, L,D-transpeptidase 5 (Ldt), Mycobacterium tuberculosis (M.tb), ONIOM, QM/MM",
author = "Tolufashe, {Gideon F.} and Sabe, {Victor T.} and Ibeji, {Collins U.} and Lawal, {Monsurat M.} and Thavendran Govender and Maguire, {Glenn E.M.} and Gyanu Lamichhane and Kruger, {Hendrik G.} and Bahareh Honarparvar",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.jmgm.2018.11.009",
language = "English (US)",
volume = "87",
pages = "204--210",
journal = "Journal of Molecular Graphics and Modelling",
issn = "1093-3263",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Inhibition mechanism of L,D-transpeptidase 5 in presence of the β-lactams using ONIOM method

AU - Tolufashe, Gideon F.

AU - Sabe, Victor T.

AU - Ibeji, Collins U.

AU - Lawal, Monsurat M.

AU - Govender, Thavendran

AU - Maguire, Glenn E.M.

AU - Lamichhane, Gyanu

AU - Kruger, Hendrik G.

AU - Honarparvar, Bahareh

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Tuberculosis (TB) is one of the world's deadliest diseases resulting from infection by the bacterium, Mycobacterium tuberculosis (M.tb). The L,D-transpeptidase enzymes catalyze the synthesis of 3 → 3 transpeptide linkages which are predominant in the peptidoglycan of the M.tb cell wall. Carbapenems is class of β-lactams that inactivate L,D-transpeptidases by acylation, although differences in antibiotic side chains modulate drug binding and acylation rates. Herein, we used a two-layered our Own N-layer integrated Molecular Mechanics ONIOM method to investigate the catalytic mechanism of L,D-transpeptidase 5 (LdtMt5) by β-lactam derivatives. LdtMt5 complexes with six β-lactams, ZINC03788344 (1), ZINC02462884 (2), ZINC03791246 (3), ZINC03808351 (4), ZINC03784242 (5) and ZINC02475683 (6) were simulated. The QM region (high-level) comprises the β-lactam, one water molecule and the Cys360 catalytic residue, while the rest of the LdtMt5 residues were treated with AMBER force field. The activation energies (ΔG#) were calculated with B3LYP, M06-2X and ωB97X density functionals with 6–311++G(2d, 2p) basis set. The ΔG# for the acylation of LdtMt5 by the selected β-lactams were obtained as 13.67, 20.90, 22.88, 24.29, 27.86 and 28.26 kcal mol−1respectively. Several of the compounds showed an improved ΔG# when compared to the previously calculated energies for imipenem and meropenem for the acylation step for LdtMt5. This model provides further validation of the catalytic inhibition mechanism of LDTs with atomistic detail.

AB - Tuberculosis (TB) is one of the world's deadliest diseases resulting from infection by the bacterium, Mycobacterium tuberculosis (M.tb). The L,D-transpeptidase enzymes catalyze the synthesis of 3 → 3 transpeptide linkages which are predominant in the peptidoglycan of the M.tb cell wall. Carbapenems is class of β-lactams that inactivate L,D-transpeptidases by acylation, although differences in antibiotic side chains modulate drug binding and acylation rates. Herein, we used a two-layered our Own N-layer integrated Molecular Mechanics ONIOM method to investigate the catalytic mechanism of L,D-transpeptidase 5 (LdtMt5) by β-lactam derivatives. LdtMt5 complexes with six β-lactams, ZINC03788344 (1), ZINC02462884 (2), ZINC03791246 (3), ZINC03808351 (4), ZINC03784242 (5) and ZINC02475683 (6) were simulated. The QM region (high-level) comprises the β-lactam, one water molecule and the Cys360 catalytic residue, while the rest of the LdtMt5 residues were treated with AMBER force field. The activation energies (ΔG#) were calculated with B3LYP, M06-2X and ωB97X density functionals with 6–311++G(2d, 2p) basis set. The ΔG# for the acylation of LdtMt5 by the selected β-lactams were obtained as 13.67, 20.90, 22.88, 24.29, 27.86 and 28.26 kcal mol−1respectively. Several of the compounds showed an improved ΔG# when compared to the previously calculated energies for imipenem and meropenem for the acylation step for LdtMt5. This model provides further validation of the catalytic inhibition mechanism of LDTs with atomistic detail.

KW - Catalytic mechanism

KW - L,D-transpeptidase 5 (Ldt)

KW - Mycobacterium tuberculosis (M.tb)

KW - ONIOM

KW - QM/MM

UR - http://www.scopus.com/inward/record.url?scp=85058218505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058218505&partnerID=8YFLogxK

U2 - 10.1016/j.jmgm.2018.11.009

DO - 10.1016/j.jmgm.2018.11.009

M3 - Article

VL - 87

SP - 204

EP - 210

JO - Journal of Molecular Graphics and Modelling

JF - Journal of Molecular Graphics and Modelling

SN - 1093-3263

ER -